Using radioactive in situ hybridisation, the distribution of prodynorphin mRNA in the brains of C57Bl/6 mice was systemically investigated, and double-labelling in situ hybridisation was used to determine the extent to which neuropeptide Y (NPY) and prodynorphin mRNAs were co-expressed. Our results demonstrate that prodynorphin mRNA expression in the mouse brain is localised at specific subregions of the olfactory bulb, cortex, hippocampus, amygdala, basal ganglia, thalamus, hypothalamus, mesencephalon and myelencephalon. Among the regions displaying the most intense labelling were the olfactory tubercle, lateral septum (LS), caudate putamen (Cpu), central amygdaloid nucleus (Ce), paraventricular hypothalamic nucleus (PVN), supraoptic nucleus (SO), lateral hypothalamic area (LHA), ventromedial hypothalamic nucleus (VMH), lateral reticular nucleus (LRt) and solitary tract nucleus (NTS). In the arcuate nucleus of the hypothalamus (Arc), doublelabelling in situ hybridisation revealed that prodynorphin expressing neurons also contained NPY mRNA, with a co-localisation rate of approximately 88% in the lateral part of the Arc, and 79% in the dorsal part of the Arc, respectively, suggesting potential overlapping functions of these two neurotransmitters in feeding type behaviour.
Introduction
Dynorphin was first isolated from the porcine pituitary gland (Goldstein et al., 1979) , was later shown to be widely expressed in the central nervous system (CNS). Dynorphin is a member of the opioid family of peptides and exerts its action through three opioid receptors, namely kappa (KOR), mu (MOR) and delta (DOR) ( Curran and Watson, 1995) , with greatest affinity for the kappa receptor. Several different types of peptides can be derived from the precursor peptide including dynorphin A, dynorphin B, dynorphin 32, α-neo-endorphin, and β-neo-endorphin ( Rossier, 1982) . Dynorphin peptides and their receptors are involved in a variety of physiological processes, including regulation of motor activity, pain modulation, inflammation response modulation, spinal nociception and energy balance ( Glass et al., 1999 , Palkovits, 2000 and Simonato and Romualdi, 1996 .
The distribution of dynorphin in the CNS has been investigated by immunohistochemical methods in the rat (Nakao et al., 1981) , hamster (Neal and Newman, 1989) and primate Khachaturian and Watson, 1982) , demonstrating discrete and high levels of dynorphin peptide levels in several CNS areas. Prodynorphin mRNA expression has also been investigated in the rat brain, showing high levels of expression in the hippocampus, striatum, amygdala and hypothalamus (Morris et al., 1986 , Sato et al., 1991 and Merchenthaler et al., 1997 . However, there are no studies so far describing the distribution and regulation of prodynorphin mRNA in the mouse brain. This is a fundamentally important question, because more and more research on the function of dynorphin or opioid receptors makes use of knockout mice models.
Dynorphin levels are highly regulated. For example, dynorphin immunoreactivity is strongly increased in the hypothalamus of rats after food deprivation and during the dark phase, suggesting a physiological role of dynorphin and kappa opioid receptors in regulating food intake ( Przewlocki et al., 1983) . The same regulation of food intake can also be seen for another orexigenic molecule, neuropeptide Y (NPY) (Sahu et al., 1988) . Interestingly, dynorphin has been shown to compete with specific binding sites for NPY on Y-receptors in vitro, suggesting that high expression of dynorphin may competitively bind to Y receptors to inhibit NPY signalling pathways (Miura et al., 1994) . Also, intracerebroventricular injection of NPY or dynorphin results in a marked increase in food intake in fasted rats (Lambert et al., 1993) , demonstrating that these two peptides may play a similar role in the central control of Lin et al.: Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain Neuropeptides 40 (2): 115--123, 2006 feeding behaviour. The arcuate nucleus of the hypothalamus is a key area in regulating food intake and energy homeostasis, where both NPY and prodynorphin mRNA are reported to be expressed. This further supports a major role for these two peptides in modulating of energy balance , Morris et al., 1986 and Sato et al., 1991 .
In order to more directly investigate the role of hypothalamic dynorphin and NPY in the regulation of energy homeostasis, we have systematically mapped the distribution of prodynorphin mRNA expression in the mouse brain and performed co-localisation experiments to investigate whether NPY and prodynorphin mRNA expression overlap.
Material and methods

Animals and tissue collection
At 16 weeks of age, 18 C57Bl/6 wild type and 6 dynorphin knockout male mice were killed by cervical dislocation, and brains were removed and immediately frozen on dry ice. Six brains from wild type mice were used to map the distribution of prodynorphin mRNA and another six wild type brains were used to examine double labelling in situ hybridisation of NPY and prodynorphin mRNA in the hypothalamus. The remaining six wild type brains were used as controls to compare prodynorphin and NPY mRNA expression to sections from dynorphin knockout mouse brains.
In situ hybridization
Coronal slices (20 µm) of fresh frozen brains were cut and thaw-mounted on charged slides and stored at −20 °C until use. For radioactive in situ hybridisation, DNA oligonucleotides complementary to mouse prodynorphin gene (5′-TTCAGGACGGGTTCCA-AGAGCTTGGCATGTGCACT GATGCCT-3′) were labelled with [
35 S] thio-dATP (Amersham Pharmacia or NEN) using terminal deoxynucleotidyltransferase (Roche, Mannheim, Germany or Amersham Pharmacia). The levels of prodynorphin mRNA expression were evaluated by measuring silver grain densities over individual neurons from photo-emulsion-dipped sections, as described previously . The density of prodynorphin mRNA was graded as "+" (weak), "++" (moderate) or "+++" (intense).
Dual labelling in situ hybridization
Dual labelling in situ hybridisation was performed by combining both radioactive and non-radioactive in situ hybridisation protocols. For the radioactive in situ hybridisation, the mouse NPY DNA oligonucleotides (5′-GAGGGTCAGTCCACACAGCCCCATTCGCTTGTTA-CCTAGCAT-3′) were labelled with [
35 S] thio-dATP as described in Section 2.2. For the nonradioactive in situ hybridisation, DNA oligonucleotides specific for the prodynorphin gene were tailed with digoxigenin at the 3′ end using terminal transferase (DIG Use's Guide Manual, Boehringer Mannheim, 1995) . Matching sections from the same portion of the Arc of dynorphin knockout and wild type control mice were used to examine prodynorphin mRNA expression and assayed together. The mixture of hybridisation solution consisted of 50% formamide, 5 × SSC (1 × SSC is 150 mM NaCl, 15 mM sodium citrate at pH 7.2), 500 µg/ml salmon sperm DNA, 250 µg/ml yeast tRNA, 1 × Denhardt's solution (0.02%Ficoll, 0.02% polyvinylpyrrolidone, and 0.02% bovine serum albumin), 10% dextran sulfate, and 20 mM dithiothreitol. The 35 S-labeled probe was diluted to 10 6 cpm/ml with the hybridisation solution, and the digoxigenin-labelled probe was used at a dilution of 2.5 pmol/ml. The hybridisation solution (100 µl) was then applied to each section and incubated for 16 h at 42 °C. The sections were washed twice in 2 × SSC with 50% formamide and 100 µl of 1 M dithiothreitol at 40 °C and twice in 2 × SSC with 50% formamide at 40 °C for 15 min each, respectively. Following the washes, we used the standard colorimetric detection system using NBT and Xphosphate to detect the digoxigenin-labelling dynorphin signals (Boehringer Mannheim, Germany). Sections were air-dried and dipped in 3% parlodion (Sigma) dissolved in diethyl ether. Slides were air-dried overnight, dipped in photographic emulsion (Kodak, Rochester, New York) and then stored in foil-wrapped slide boxes at 4 °C for 2 weeks. Slides were developed with D-19 developer (Kodak, Rochester, New York), and then immersed in distilled water and cover-slipped with Aquamount ® (Merck KGaA, Dannstadt, Germany).
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Quantitation
Cell counting was performed using a grid reticule and the 10× objective of a Zeiss Axioplan light microscope (Oberkochen, Germany). Double labelled cells within the Arc were delineated through adjacent landmarks, according to the atlas of the mouse brain in stereotaxic coordinates by Franklin and Paxinos (Franklin and Paxinos, 1997) . The positively double-labelled cells were counted if the number of silver grains overlying identified neuron bodies (digoxigenin-labelled) were five times higher than background levels. The values represent an average of positive neurons in a given area of one hemisphere from a single section. The average cell counts per area were determined by both left and right sides of the coronal sections, and then all groups were pooled for final analyses.
Results
Distribution of the prodynorphin mRNA in mouse brain
The most prominent prodynorphin mRNA expression was found in specific subregions of the cortex, olfactory bulb, hippocampus, amygdala, basal ganglia, thalamus, hypothalamus, mesencephalon and myelencephalon (Table 1) . A detailed description of the specific localisation of prodynorphin mRNA is given below.
Telencephalon
In cortical regions, moderate hybridisation signals were observed over neurons in cingulate and layer 3 of the piriform cortices. Low signals were seen in primary somatosensory, agranular insular, perirhinal, lateral entorhinal and retrosplenial cortices. Neurons in the olfactory bulb and anterior olfactory nucleus exhibited weak hybridisation signals, while intensely labelled neurons were seen in the olfactory tubercle. A large number of intensely labelled neurons were also observed in the caudate putamen ( Fig. 4a and b) , and moderate to highly labelled neurons were found in the nucleus accumbens (core region, medial and dorsal to anterior commissure). Low to moderate hybridisation signals were expressed in the septal area, most of which were localised at the lateral septum. In the hippocampus, the granular cell layer of the dentate gyrus displayed moderate hybridisation signals while weak signals were shown in the pyramidal cell layer throughout the hippocampal proper (CA1-3) and striatum lucidem of the hippocampus.
In the amygdala, hybridisation signals were widespread over many nuclei with particular intense signals found in the medial ( Fig. 4c and d ) and lateral parts of cental amygdaloid nucleus. In addition, moderate signal was seen in the posterior part of medial amygdaloid and basolateral amygdaloid nuclei. In the bed nucleus of the stria terminalis, the lateral subdivisions contained weakly labelled neurons. Caudally, amygdalalohippocampal areas exhibited subpopulations of moderately labelled neurons. Weak labelling was observed in the entopeducular nucleus and ventral pallidum.
Diencephalon
In the thalamus, prodynorphin mRNA was sparsely distributed. A few neurons in the central medial thalamic and the medial habenular nuclei were moderately labelled, while small groups of neurons in the reticular nucleus and zona incerta were weakly labelled ( Fig.  1) .
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Mesencephalon and mylencephalon
Few regions of the midbrain and hindbrain were shown to contain significant levels of prodynorphin mRNA (Table 1, Fig. 4) . Sporadic positive neurons were evident in the inferior colliculus, dorsal raphe nucleus, peripeduncular nucleus and periaqueductal gray. The lateral part of substantia nigra and parabrachial nucleus were observed only a very scattered prodynorphin mRNA. The solitary tract nucleus (Fig. 4e and f) and lateral reticular nucleus contained intensely labelled cells.
3.5. Co-localisation of NPY and prodynorphin mRNA in (data not shown), however, several other parts of the brain including the central amygdala (approx 30%), the posterior part of the medial amygdala (approx 25%) and the caudata putamen (approx 25%) show colocalisation of NPY and dynorphin mRNA. As a control, no prodynorphin mRNA expression was shown in the Arc of dynorphin knockout mice (Fig. 5b) . Interestingly, the NPY mRNA expression level in the arc of dynorphin knockout mice was reduced by approxi- 
Few regions of the midbrain and hindbrain were shown to contain significant levels of prodynorphin mRNA (Table 1, Fig. 4 ). Sporadic positive neurons were evident in the inferior colliculus, dorsal raphe nucleus, peripeduncular nucleus and periaqueductal gray. The lateral part of substantia nigra and parabrachial nucleus were observed only a very scattered prodynorphin mRNA. The solitary tract nucleus ( Fig. 4e and f) and lateral reticular nucleus contained intensely labelled cells.
by the fact that after food deprivation, both NPY and prodynorphin mRNA are significant increased in the hypothalamus (Przewlocki et al., 1983; Sahu et al., 1988) . Furthermore, prodynorphin mRNA expression is increased five-fold in the DMN of leptin deficient ob/ob mice (Khawaja et al., 1991) , the DMN being a region that shows intense dynorphin expression in the mouse. Therefore, it is possible that dynorphin and NPY interact within the hypothalamus in the regulation of food intake and energy homeostasis.
The present study also demonstrates a conserved expression pattern for the prodynorphin mRNA in the mouse brain compared to rats. The regions that exhibited highest hybridisation signals for prodynorphin mRNA include the olfactory tubercle, caudate putamen, sub-group of the amygdala, most of the hypothalamic nuclei, and several brain stem nuclei. However, there were also differences found between the prodynorphin mRNA expression in the mouse to that of the rat, particularly in the central amygdaloid and the lateral reticular nucleus which displayed intense signals in the mouse, but only low to moderate signals in the rat (Merchenthaler et al., 1997) .
Overall our results are consistent with immunohistochemistry studies investigating the distribution of dynorphin neurons in the rat brain (Fallon and Leslie, 1986) . In the striatal region, we found the strongest prodynorphin mRNA expression in the olfactory tubercle, caudate putamen and nucleus accumbens. Previous studies show that prodynorphin mRNA is expressed in GABAergic neurons in the stratum, projecting to the substantia nigra and pallidum (Graybiel, 1986) , and that dynorphin gene expression is controlled by the dopaminergic (Morris et al., 1988) and serotoninergic systems (Morris et al., 1988) . The nucleus accumbens receive inputs mainly from the limbic system, which then sends outputs to the ventral pallidum and ventral tegmental area. Strong dynorphin signal was displayed in the striatal region, suggesting that dynorphin may play a role in the regulation of adaptive behavioural response, stress, drug abuse, obsessive compulsive disorders, seizures and psychoses (Laughlin et al., 2001 ; Shippenberg and Rea, 1997; Shirayama et al., 2004; Simonato and Romualdi, 1996) . Our results show high levels of prodynorphin mRNA expression in the dentate gyrus of the mouse brain, which supports previous reports that dynorphin-derived peptides are synthesised in the granule cells of the dentate gyrus in rats, which is then transported to the axon terminals in the C3 region of the hippocampus (Morris and Johnston, 1995) . High levels of dynorphin in the dentate gyrus have been suggested to be involved in seinucleus, which provide both ascending innervations to the hypothalamus and descending projections to the spinal cord. Both of these nuclei are also strategically located in brain regions that have long been associated with the regulation of autonomic functions such as the cardiovascular, respiratory and nociceptive control mechanisms.
In addition, strong prodynorphin mRNA expression is found in the PVN and SO. In the PVN, intense prodynorphin mRNA expression is shown in the posterior 
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Co-localisation of NPY and prodynorphin mRNA in the hypothalamus
In order to investigate the possible interaction of dynorphin with the NPY system we performed double-labelling experiments employing NPY 35 S-labelled and prodynorphindigoxigenin-labelled probes. The largest numbers of co-expressing neurons were found in the Arc (Fig. 5c and d) . NPY mRNA was co-expressed in approximately 80% of Arc dynorphin neurons (79% located in the dorsal part of Arc and 88% located in lateral part of Arc). No colocalisation of NPY and dynorphin could be detected in any other hypothalamic nuclei (data not shown), however, several other parts of the brain including the central amygdala (approx 30%), the posterior part of the medial amygdala (approx 25%) and the caudata putamen (approx 25%) show co-localisation of NPY and dynorphin mRNA. As a control, no prodynorphin mRNA expression was shown in the Arc of dynorphin knockout mice (Fig. 5b) . Interestingly, the NPY mRNA expression level in the arc of dynorphin knockout mice was reduced by approximately 26% (Fig. 6) further suggesting a close interaction between these two neurotransmitter systems.
Discussion
This study shows for the first time that Arc NPY neurons contain prodynorphin mRNA. Previously, it has been known that peripherally administrated leptin induces c-fos expression in dynorphin positive neurons in the Arc, suggesting that like NPY, dynorphin is also regulated by leptin (Elias et al., 2000) . This is supported by the fact that after food deprivation, both NPY and prodynorphin mRNA are significant increased in the hypothalamus (Przewlocki et al., 1983 and Sahu et al., 1988) . Furthermore, prodynorphin mRNA expression as in the parvicellular neurons in the LH (Smart and Jerman, 2002 ).
We also demonstrate co-localisation of prodynorphin mRNA with NPY in several brain areas. Whereas coexpression in different parts of the amygdala indicate overlapping or coordinated function in anxiety-related behaviours the highest extend of overlap of NPY and dynorphin is found in neurons of the Arc. This supports a potential coordinated function of dynorphin and NPY in the modulation of energy homeostasis and neuroendocrine regulation. Further evidence for this comes from the observed down regulation of NPY mRNA in dynorphin knockout mice.
In summary, the present study provides a precise map of prodynorphin mRNA expression and coexpression with NPY in the mouse brain, which will facilitate interpretation and design of dynorphin or opioid receptors knockout and conditional knockout studies in mice. is increased five-fold in the DMN of leptin deficient ob/ob mice ( Khawaja et al., 1991) , the DMN being a region that shows intense dynorphin expression in the mouse. Therefore, it is possible that dynorphin and NPY interact within the hypothalamus in the regulation of food intake and energy homeostasis.
Overall our results are consistent with immunohistochemistry studies investigating the distribution of dynorphin neurons in the rat brain (Fallon and Leslie, 1986) . In the striatal region, we found the strongest prodynorphin mRNA expression in the olfactory tubercle, caudate putamen and nucleus accumbens. Previous studies show that prodynorphin mRNA is expressed in GABAergic neurons in the stratum, projecting to the substantia nigra and pallidum (Graybiel, 1986) , and that dynorphin gene expression is controlled by the dopaminergic (Morris et al., 1988) and serotoninergic systems (Morris et al., 1988) . The nucleus accumbens receive inputs mainly from the limbic system, which then sends outputs to the ventral pallidum and ventral tegmental area. Strong dynorphin signal was displayed in the striatal region, suggesting that dynorphin may play a role in the regulation of adaptive behavioural response, stress, drug abuse, obsessive compulsive disorders, seizures and psychoses (Laughlin et al., 2001 , Shippenberg and Rea, 1997 , Shirayama et al., 2004 and Simonato and Romualdi, 1996 .
Our results show high levels of prodynorphin mRNA expression in the dentate gyrus of the mouse brain, which supports previous reports that dynorphin-derived peptides are synthesised in the granule cells of the dentate gyrus in rats, which is then transported to the axon terminals in the C3 region of the hippocampus (Morris and Johnston, 1995) . High levels of dynorphin in the dentate gyrus have been suggested to be involved in seizures as well as addictive drug and alcohol-seeking behaviour , Morris and Johnston, 1995 and Romualdi et al., 1991 . In the amygdala area, there are intense to moderate hybridisation signals in several subregions such as the central amygdala, bed nucleus of stria terminals and basolateral amygdaloid nucleus suggesting an involvement of dynorphin in mood disorders, depression and stress-related changes in pain sensitivity (Hurd, 2002 and Schulz et al., 1996) . Here we also show that there are high level of prodynorphin mRNA expression in the NTS and lateral reticular nucleus, which provide both ascending innervations to the hypothalamus and descending projections to the spinal cord. Both of these nuclei are also strategically located in brain regions that have long been associated with the regulation of autonomic functions such as the cardiovascular, respiratory and nociceptive control mechanisms.
In addition, strong prodynorphin mRNA expression is found in the PVN and SO. In the PVN, intense prodynorphin mRNA expression is shown in the posterior PVN as well as the medial and lateral magnocellular part of the PVN. Co-localisation of dynorphin and oxytocin or vasopressin neurons in the magnocellular neurons of the PVN and SO has been reported (Meister et al., 1990) , suggesting an important role for dynorphin in the control of prolactin secretion and water homeostasis. In addition, colocalisation of prodynorphin with two other neuropeptides (Cocaine and amphetamine regulated transcript and Orexin), which play an important role in the regulation of feeding behaviour, has been shown in the PVN and SON (Elias et al., 2001) , as well as in the parvicellular neurons in the LH (Smart and Jerman, 2002) .
We also demonstrate co-localisation of prodynorphin mRNA with NPY in several brain areas. Whereas co-expression in different parts of the amygdala indicate overlapping or coordinated function in anxiety-related behaviours the highest extend of overlap of NPY and dynorphin is found in neurons of the Arc. This supports a potential coordinated function of dynorphin and NPY in the modulation of energy homeostasis and neuroendocrine regulation. Further evidence for this comes from the observed down regulation of NPY mRNA in dynorphin knockout mice.
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